• Acumen Detection

    Acumen Detection worked with researchers at Cornell University to develop innovative assays and incorporate Real-Time PCR for detection that is specific, sensitive and rapid. We also introduced the Acu-POLARIS (Portable Onsite Laboratory And Rapid Identification System), empowering producers to make faster, more informed management decisions.

  • American Chestnut Research and Restoration Project

    American Chestnut Research and Restoration Project

    The American Chestnut Research and Restoration Project is currently occupying Suite 1300 at the CNY Biotechnology Accelerator. In their lab, genetically engineered, blight resistant American chestnut plantlets are being acclimated from sterile culture conditions to newly installed, state of the art, high-humidity and high-light growth chambers. Fertilizer regimes, media substrates, and various other variables are being tested to improve plantlet growth and survival during the acclimatization process. The transgenic trees will be used in field plantings to test blight resistance and non-target effects. Eventually this lab will be the main production facility for our blight resistant American chestnut trees being reviewed by the federal regulatory agencies, with a goal of producing 10,000 American chestnut trees in five years to be ready for distribution once approval is received.
    Can science help the American chestnut make a comeback?  11/22/2016

    More ...
  • ANDRO Computational Solutions, LLC

    ANDRO is a small, for-profit research and development company.  The company is headquartered in Rome, NY with offices in Dayton, OH, and now at the CNY Biotech Accelerator in Syracuse, NY, with a soon to be established office in the Washington, DC area.  The company focuses on defense-related technologies in the areas of:

    • Radio Frequency (RF) Spectrum Management
    • Electromagnetic Environmental Effects (E3) computer modeling, simulation and analysis
    • Computational Electromagnetics (CEM) tool development
    • Cognitive Software Defined Radio (SDR) technologies
    • Secure RF Wireless Communications
    • Cyber-domain Spectrum Exploitation
    • Cyber Electromagnetic Activities (CEMA)
    • Sensor Resource Management (SRM)
    • Multisensor Data Fusion

    Our commercial subsidiary, Spectrum Fusion, Inc. is an ANDRO company that focuses on Autonomous Systems technologies and applications for the Internet of Things marketplace with special emphasis on UAS/V Command and Control (C2) technologies, medical sensing devices and emerging technologies for “big data” management.  Spectrum Fusion provides Spectrum Management as a Service (SMaaS) functions to industry focusing on independent RF spectrum analysis and testing pre-certification services including performance of spectrum site surveys

    ANDRO is a recognized leader and member of the National Spectrum Consortium (NSC). The company was awarded the coveted Tibbetts Award from the Small Business Administration (SBA) for Excellence in the Federal Small Business Innovation Research (SBIR) Program and was presented the award at the White House in 2015.

    ANDRO is also the catalyst for its non-profit activity called The Project FibonacciÒ Foundation, Inc., which provides youth-centered alternative learning and cross-education programs in STEAM (Science, Technology, Engineering, Arts & Math) disciplines.

    More ...
  • AptaMatrix, Inc.

    AptaMatrix Inc. is a biotechnology firm leveraging next-gen sequencing technology to accelerate aptamer discovery. Aptamers are non-coding nucleic acid molecules that have the ability to bind to protein targets will high affinity and specificity. Aptamers are the nucleic acid equivalent of a monoclonal antibody, and viable as therapeutic agents and for detection/diagnostic applications. Using AptaMatirx's proprietary workflow, aptamer discovery can be reduced to 2 weeks with an anticipated reduction to 3 days. AptaMatrix specializes in screening modified nucleic acid libraries that are difficult to screen using traditional SELEX aptamer discovery methods.

    More ...
  • Carapace


    Company Info Coming Soon!

  • CathBuddy


    CathBuddy is making urinary intermittent catheters safely reusable in order to raise the standard of care for people with neurogenic bladder while reducing overall healthcare costs.  Started after the founder's good friend sustained a spinal cord injury and became reliant on urinary catheters, CathBuddy, Inc. is committed to developing a user-centered urinary catheterization system that is sustainable, affordable, and above all, healthy. The system is comprised of an at-home sterilization unit, a reusable catheter insertion aid, and a reusable urinary catheter. Selected as a 2019 FuzeHub Commercialization Competition finalist.

    More ...
  • Complex Biosystems

    Our mission is to equip mainly Life Science but also Engineering firms with products & services allowing them to take advantage of modeling and simulations to timely develop processes and devices. Our software can streamline complex manipulations, reduce time on task, and increase the quality of end products. We are also prepared to prototype complex electronic and more specifically Medical devices. With us design starts with a good understanding of the underlying processes which we usually model. Simulations enable to draw more precise specifications. This way we conceive effective prototypes in just a few iterations. 

    More ...
  • Cormac Life Sciences

    Cormac Life Sciences is a Veterans Affairs and New York State certified Service Disabled Veteran-Owned Small Business (SDVOSB) delivering life sciences research and support services.  

    We provide expertise across a range of biopreparedness disciplines to include biosurveillance, basic and translational sciences, clinical research, and essential support services such as quality assurance, field site development and regulatory affairs services.

    We are led by physician-scientists, technology executives, and health care business development experts with established connections across government, industry and academia.

    Our mission is to support global health security and biopreparedness objectives. We are committed to providing innovative, agile and client-centered solutions with a focus on New York State and U.S. Government clients

    More ...
  • EndoGlow

    EndoGlow is a 2017 Medical Device Innovation Challenge participant.  EndoGlow designs and manufactures fluorescent medical devices that improve patient safety, enhance surgical efficiency, and reduce costs.

  • Expressive Neuroscience

    Expressive Neuroscience

    Expressive Neuroscience is developing an industry-leading assay platform to evaluate CNS gene therapy vectors. This platform will combine cutting edge informatics, tissue handling, DNA sequencing and imaging technologies. The precision, power, and scale of the Expressive platform will provide the clear metrics required to move the most promising candidate vectors toward the clinic. The Expressive Neuroscience team has the deep expertise in neuroscience, informatics and assay development.

    More ...

    A highly innovative approach has been optimized for efficient generation, selection, and expansion of high affinity monoclonal antibodies with neutralizing activity and unique amino acid structure. A fully human antibody could significantly reduce potential immune responses, as compared to antibody therapeutics that contain nonhuman components.

    ILGEN's technology allows to detect and generate different specific high-affinity fully human antibodies for antibody-based therapy and diagnosis. In addition to cancer treatment many other conditions effectively treated by an ILGEN's human antibodies could include infections, rheumatic and autoimmune diseases, vascular and lymphoproliferative disorders. ILGEN has patent application.

    The therapeutic or diagnostic fully human antibodies and fusion proteins of the present technology are those derived from human tissues with further possibility to be purified, scale-up produced appropriate quantities and used in treatment or diagnosis of human diseases as pharmaceutical agents.

    Advantage of our approach is a significant reduction in turnaround time. It typically takes 1-2 years to obtain functionally validated and sequenced antibodies using traditional hybridoma and humanization methods or phage libraries. In con­trast, it would take no more than 6 months using our approach.

    More ...
  • LifeUnit


    LifeUnit, Inc., a recent Grants for Growth Awardee, is a privately held biotechnology company focused on the development of novel therapeutics and chemical agents for treating and controlling biofilm formation and other bacterial activities.
    Biofilm is a multicellular organism formed by bacteria transforming from living in solution to multiple phenotypes living in a structured, wet organic film. Biofilms contribute to drug resistance, persistent infections and health conditions including Cystic Fibrosis (CF) and Acne Vulgaris (acne), and many others. LifeUnit's product development efforts are currently focused on optimizing a novel class of small organic molecules, and on elucidating the new biological mechanism, that have unprecedented efficacy for preventing and reducing biofilm formation. This line of chemical innovation has immediate applications for Cystic Fibrosis and Skin Cares.
    For more information contact:

    More ...
  • Pelitex

    Pelitex is a Product Development and Technology Licensing firm with an IP license to practice and exploit a key disruptive technology called Nanogradient™ materials.Nanogradient™ is a customizable nanoscale alloy that exhibits magnetic, electrical, thermal, mechanical, and anti-­‐corrosive properties critical to the performance of products across many market and industry sectors. This technology is utilized to fabricate pure nano-­‐scale materials that exhibit high super-­‐paramagnetic characteristics as well as extremely high thermal and electrical conductivity. Additionally, the material is exceptionally stable, impermeable, and resistant to corrosion. It can also be functionalized, magnetically tuned, and chemically conjugated to address a number of difficult problems across multiple market segments and industry applications. In broad terms, Pelitex’s technology has performance advantages and competitive attributes in just about any industry area where ferric oxide is used for its magnetic capabilities. The Nanogradient™ technology was developed over the last ten years, and is now a seminal platform technology capable of changing/disrupting the market landscape now occupied by iron oxide, due to its extremely enhanced magnetism, stability, and related attributes.

    More ...
  • Quadrant Biosciences

    Developing solutions for important global health issues

    Quadrant Biosciences works with top academic institutions, medical researchers and engineers to translate breakthrough findings into thoughtfully developed and scientifically sound assessment applications.

    Our evolutionary advancements in brain health assessment, autism and Parkinson’s detection, will have a significant impact on the way clinicians approach the diagnosis and treatment of these serious conditions going forward. Supported through private and state funding, one of these key technologies, ClearEdge, is currently available in the market and the others are slated for a 2018 release.

    More ...
  • Repair Biotechnologies

    Repair Biotechnologies is a biotechnology company with the mission to develop and bring to the clinic therapies that significantly improve human healthspan through targeting the causes of age-related diseases and aging itself.

  • Syracuse Biolabs

    Syracuse Biolabs focuses on commercial development of early stage biochemical based technologies, including but not limited to, diagnostics, biosensing, therapeutics, medical technology and assay development

  • Upstate 3D Printing Initiative

    Upstate Medical Students Create 3D-Printed Prosthetics
    Medical Students:  Zach Visco, Eric Merrell and Jade Marhaba
    Three SUNY Upstate Medical University students have already created two plastic hand models. They'll allow a child or adult to pick up an object or hold a cup.  It's all thanks to the the Upstate Biotech Accelerator.

    Zach Visco says it takes about a day to produce and assemble the prosthetic. Among the benefits -- accessibility and cost.  Patients would be paying about $20 instead of thousands.

    "We know kids are going to be breaking them," said Visco. "We know kids like to test them out, kids are going to fall, kids are going to outgrow things. So, if we kind of remove the stress of a child breaking or growing out of their prosthetic for a family, we know they will get a lot more use, stress-free use out of this device."

    The students are trying to find a person in need of the device.

    More ...
  • Vectorial Synthesis Tech

    Our mission is to provide a new tool for researchers and industry to simplify the protein expression process. Our new tool promises fast and simple expression methods with minimal purification right on your bench.
  • Yadometer

    Founded by Upstate Resident, Cesar Colasante, Yadometer is a touch-free, quick and reliable solution to measure ROM of the hand.  Measuring the ROM of the joints of the hand is an essential part of the hand exam. Trauma, degenerative disease, among other can cause impaired ROM. Currently the only method to objectively measure ROM of the hand is using a goniometer a cumbersome, operator dependent tool that takes a significant amount of time to generate the values of all joints of the hand.  Yadometer uses the Leap Motion device to track the movements of the joints of the hand and generate ROM values... IN SECONDS.  

    More ...
  • Zetagen Therapeutics

    Zetagen Therapeutics (formerly Fusologics), is a pre-clinical orthopedics company developing products that activate a novel and proprietary molecular pathway for growing bone.  Discovered by accident, Fusologics' first product, Nalfuse, addresses a large unmet need for the $4b orthobiologics market and several high volume medical applications for which bone growth leads to optimal outcomes. Based on published pre-clinical data, Nalfuse activates this molecular pathway with a combination of a collagen carrier and an FDA-approved small molecule with over 40 years of high dosage, systemic clinical use for a different indication. As opposed to other products on the market that contain biologic growth factors, such as Medtronic's Infuse (BMP2), which at its peak accounted for ~$900m revenue per year but has since seen a precipitous decline in use due to high cancer risk and significant side effects, Nalfuse has shown the potential to be safer, significantly less costly to manufacture and grow bone just as effectively, if not better.

    More ...
  • ZephyRx


    ZephyRx creates video games for respiratory therapy. Our games coupled with a custom, breath­activated game controller have shown to increase patient compliance as much as 20X.  In our $1.8M NIH­sponsored clinical trial we apply video games to well­known respiratory therapy exercises to address pneumonia, asthma, COPD and cystic fibrosis. We started our business in 2007 and design, produce and sell worldwide breath­powered musical instruments and breath­powered video game controllers for the disabled.

    More ...